Jacob Sands

New Capabilities

Presented DeLLphi-305 results at the ESMO Congress 2026 Presidential Symposium

Small cell lung cancer that has spread through the chest and beyond has held median survival near a year for decades. A phase 3 trial presented Oct. 24 at the ESMO Congress raised that to 21.1 months, about eight months longer than the comparison arm.

Updated Oct 26